Lucioni, Carlo, Sergio Iannazzo, Silvio Mazzi, Giorgia Saporiti, and Silvia Chiroli. “Cost-Effectiveness of Ponatinib in Chronic Myeloid Leukemia in Italy: Valutazione Di Costo-Efficacia Di Ponatinib Nella Terapia Della Leucemia Mieloide Cronica in Italia”. Global and Regional Health Technology Assessment 2, no. 1 (March 17, 2015): 1–16. Accessed November 24, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/320.